市場調查報告書

癌症病患註冊軟體的全球市場:市場機會分析及未來預測

Global Cancer Registry Software Market Size study, by Type, by Deployment Model, by Database Type, By Functionality, by End-User and Regional Forecasts 2019-2026

出版商 Bizwit Research & Consulting LLP 商品編碼 916180
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
癌症病患註冊軟體的全球市場:市場機會分析及未來預測 Global Cancer Registry Software Market Size study, by Type, by Deployment Model, by Database Type, By Functionality, by End-User and Regional Forecasts 2019-2026
出版日期: 2019年11月08日內容資訊: 英文
簡介

本報告提供癌症病患註冊軟體的世界市場調查,市場概要,各類型、終端用戶、地區的市場趨勢,市場規模的變化與預測,市場促進、阻礙因素以及市場機會分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 摘要整理

  • 市場概述
  • 全球的及市場區隔的市場預測,2017年-2026年(百萬美元)
    • 各類型
    • 各部署模型
    • 各資料庫類型
    • 各功能
    • 各終端用戶
    • 各地區
  • 主要的趨勢
  • 預測方法
  • 調查的前提條件

第2章 市場定義和範圍

  • 調查的目的
  • 市場定義和範圍
    • 調查範圍
    • 產業的演進
  • 調查期間
  • 貨幣換算比率

第3章 市場動態

  • 市場影響分析(2018-2026)
    • 成長要素
    • 市場課題
    • 市場機會

第4章 市場產業分析

  • 五力分析模型
    • 供應商談判力
    • 買方議價能力
    • 新加入廠商的威脅
    • 替代品的威脅
    • 競爭企業
    • 對五力分析模型的未來方法(2016-2026)
  • PEST分析
    • 政治方案
    • 經濟方案
    • 社會方案
    • 技術方案
  • 投資採用模式
  • 分析師的推薦和結論

第5章 癌症病患註冊軟體市場:各類型

  • 市場概述
  • 種類,效能-潛在性分析
  • 市場估計值及預測,2016年-2026年(百萬美元)
  • 子區隔分析
    • 獨立式軟體
    • 整合型軟體

第6章 癌症病患註冊軟體市場:各部署模型

  • 市場概述
  • 部署模型,效能-潛在性分析
  • 市場估計值及預測,2016年-2026年(百萬美元)
  • 子區隔分析
    • 內部部署
    • 雲端基礎

第7章 癌症病患註冊軟體市場:各資料庫類型

  • 市場概述
  • 各部署模型,效能-潛在性分析
  • 市場估計值及預測,2016年-2026年(百萬美元)
    • 商用資料庫
    • 公開資料庫

第8章 癌症病患註冊軟體市場:各功能

  • 市場概述
  • 功能,效能-潛在性分析
  • 市場各功能預測,預測,2016年∼2026年(百萬美元)
    • 聯邦/州政府法規遵守用
    • 患者照護管理
    • 醫學研究、臨床研究
    • 產品成果評估

第9章 癌症病患註冊軟體市場:各終端用戶

  • 市場概述
  • 部署模型,效能-潛在性分析
  • 市場估計值及預測,2016年-2026年(百萬美元)
    • 政府機關、TPA (事務代理公司)
    • 醫院、診療所
    • 民間保險付款者
    • 製藥/生物科技/醫療設備企業
    • 研究中心

第10章 癌症病患註冊軟體市場:各地區

  • 地區市場概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他
  • 中南美
    • 巴西
    • 墨西哥
  • 其他

第11章 競爭情形

  • 首位市場策略
  • 企業簡介
    • Onco, Inc.
    • C/Net Solutions
    • Elekta AB (PUB)
    • Rocky Mountain Cancer Data Systems
    • Electronic Registry Systems, Inc.
    • Mckesson Corporation

第12章 調查方法

  • 調查方法
    • 資料探勘
    • 分析
    • 市場預測
    • 檢驗
    • 出版
  • 調查屬性
  • 調查的前提條件
目錄

Global Cancer Registry Software Market is valued approximately at USD 50.68 million in 2018 and is anticipated to grow with a healthy growth rate of more than 10.5% over the forecast period 2019-2026. Cancer registry is a computerized database which uses software solutions to organize, gather and store data of the cancer patients and evaluate cancer-specific upshots, situations and drug/medical device exposure. Growing number of cancer cases, increasing adoption of EHR, favorable government programs towards cancer and growing use of cancer patient registry data for post-marketing surveillance are the few factors responsible for high CAGR of the market over the forecast period. For instance, In 2018, it was estimated that there were 17.0 million new cancer cases and 9.5 million cancer deaths worldwide. The global burden of cancer is expected to grow to 27.5 million new cancer cases and 16.3 million cancer deaths by 2040 due to the growth and aging of the population, according to the International Agency for Research on Cancer (IARC). Owing to Tthe prevalence of cancer is on surging trend thereby escalating, the need for cancer registry software is also increased all over the world. Moreover, increasing number of accountable care organizations and growth of cloud-based cancer patient registry solutions is the major factor likely to create lucrative growth opportunity to the market in the upcoming years. However, privacy and data security-related concerns is one of the major factors anticipated to limiting the growth of global cancer registry software market during the forecast period.

The regional analysis of global Cancer Registry Software Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising prevalence of cancer, government funding initiatives to encourage the development of cancer registries and high investments in healthcare IT across the region. However, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026.

Major market player included in this report are:

  • Onco, Inc.
  • C/Net Solutions
  • Elekta AB (PUB)
  • Rocky Mountain Cancer Data Systems
  • Electronic Registry Systems, Inc.
  • MckessonMcKesson Corporation

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Standalone Software
  • Integrated Software

By Deployment Model:

  • On-premise
  • Cloud-Based

By Database Type:

  • Commercial Database
  • Public Database
  • By Functionality:
  • Cancer Reporting to Meet State and Federal Regulations
  • Patient Care Management
  • Medical Research & Clinical Studies
  • Product Outcome Evaluation

By End-User:

  • Government Organizations & Third-Party Administrators
  • Hospitals & Medical Practices
  • Private Players
  • Pharmaceutical, Biotechnology, and Medical Device Companies
  • Research Centers

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • Asia Pacific
  • China
  • India
  • Japan
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

  • Historical year - 2016, 2017
  • Base year - 2018
  • Forecast period - 2019 to 2026

Target Audience of the Global Cancer Registry Software Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Million)
    • 1.2.1. Cancer Registry Software Market, by Type, 2017-2026 (USD Million)
    • 1.2.2. Cancer Registry Software Market, by Deployment Model, 2017-2026 (USD Million)
    • 1.2.3. Cancer Registry Software Market, by Database Type, 2017-2026 (USD Million)
    • 1.2.4. Cancer Registry Software Market, by Functionality, 2017-2026 (USD Million)
    • 1.2.5. Cancer Registry Software Market, by End-User, 2017-2026 (USD Million)
    • 1.2.6. Cancer Registry Software Market, by Region, 2017-2026 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Cancer Registry Software Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Cancer Registry Software Market Dynamics

  • 3.1. Cancer Registry Software Market Impact Analysis (2018-2026)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Cancer Registry Software Market Type Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2016-2026)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Cancer Registry Software Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Cancer Registry Software Market by Type, Performance - Potential Analysis
  • 5.3. Global Cancer Registry Software Market Estimates & Forecasts by Type 2016-2026 (USD Million)
  • 5.4. Cancer Registry Software Market, Sub Segment Analysis
    • 5.4.1. Standalone Software
    • 5.4.2. Integrated Software

Chapter 6. Global Cancer Registry Software Market, by Deployment Model

  • 6.1. Market Snapshot
  • 6.2. Global Cancer Registry Software Market by Deployment Model, Performance - Potential Analysis
  • 6.3. Global Cancer Registry Software Market Estimates & Forecasts by Deployment Model, 2016-2026 (USD Million)
  • 6.4. Cancer Registry Software Market, Sub Segment Analysis
    • 6.4.1. On-premises
    • 6.4.2. Cloud-based

Chapter 7. Global Cancer Registry Software Market, by Database Type

  • 7.1. Market Snapshot
  • 7.2. Global Cancer Registry Software Market by Deployment Model, Performance - Potential Analysis
  • 7.3. Global Cancer Registry Software Market Estimates & Forecasts by Deployment Model, 2016-2026 (USD Million)
    • 7.3.1. Commercial Databases
    • 7.3.2. Public Databases

Chapter 8. Global Cancer Registry Software Market, by Functionality

  • 8.1. Market Snapshot
  • 8.2. Global Cancer Registry Software Market by Functionality, Performance - Potential Analysis
  • 8.3. Global Cancer Registry Software Market Estimates & Forecasts by Functionality, 2016-2026 (USD Million)
    • 8.3.1. Cancer Reporting to Meet State and Federal Regulations
    • 8.3.2. Patient Care Management
    • 8.3.3. Medical Research & Clinical Studies
    • 8.3.4. Product Outcome Evaluation

Chapter 9. Global Cancer Registry Software Market, by End-User

  • 9.1. Market Snapshot
  • 9.2. Global Cancer Registry Software Market by Deployment Model, Performance - Potential Analysis
  • 9.3. Global Cancer Registry Software Market Estimates & Forecasts by Deployment Model, 2016-2026 (USD Million)
    • 9.3.1. Government Organizations & Third-Party Administrators
    • 9.3.2. Hospitals & Medical Practices
    • 9.3.3. Private Payers
    • 9.3.4. Pharmaceutical, Biotechnology, and Medical Device Companies
    • 9.3.5. Research Centers

Chapter 10. Global Cancer Registry Software Market, Regional Analysis

  • 10.1. Cancer Registry Software Market, Regional Market Snapshot
  • 10.2. North America Cancer Registry Software Market
    • 10.2.1. U.S. Cancer Registry Software Market
      • 10.2.1.1. Type breakdown estimates & forecasts, 2016-2026
      • 10.2.1.2. Deployment Model breakdown estimates & forecasts, 2016-2026
      • 10.2.1.3. Database Type breakdown estimates & forecasts, 2016-2026
      • 10.2.1.4. Functionality breakdown estimates & forecasts, 2016-2026
      • 10.2.1.5. End-User breakdown estimates & forecasts, 2016-2026
    • 10.2.2. Canada Cancer Registry Software Market
  • 10.3. Europe Cancer Registry Software Market Snapshot
    • 10.3.1. U.K. Cancer Registry Software Market
    • 10.3.2. Rest of Europe Cancer Registry Software Market
  • 10.4. Asia-Pacific Cancer Registry Software Market Snapshot
    • 10.4.1. China Cancer Registry Software Market
    • 10.4.2. India Cancer Registry Software Market
    • 10.4.3. Japan Cancer Registry Software Market
    • 10.4.4. Rest of Asia Pacific Cancer Registry Software Market
  • 10.5. Latin America Cancer Registry Software Market Snapshot
    • 10.5.1. Brazil Cancer Registry Software Market
    • 10.5.2. Mexico Cancer Registry Software Market
  • 10.6. Rest of The World Cancer Registry Software Market

Chapter 11. Competitive Intelligence

  • 11.1. Top Market Strategies
  • 11.2. Company Profiles
    • 11.2.1. Onco, Inc.
      • 11.2.1.1. Key Information
      • 11.2.1.2. Overview
      • 11.2.1.3. Financial (Subject To Data Availability)
      • 11.2.1.4. Product Summary
      • 11.2.1.5. Recent Developments
    • 11.2.2. C/Net Solutions
    • 11.2.3. Elekta AB (PUB)
    • 11.2.4. Rocky Mountain Cancer Data Systems
    • 11.2.5. Electronic Registry Systems, Inc.
    • 11.2.6. Mckesson Corporation

Chapter 12. Research Process

  • 12.1. Research Process
    • 12.1.1. Data Mining
    • 12.1.2. Analysis
    • 12.1.3. Market Estimation
    • 12.1.4. Validation
    • 12.1.5. Publishing
  • 12.2. Research Attributes
  • 12.3. Research Assumption

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL CANCER REGISTRY SOFTWARE MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL CANCER REGISTRY SOFTWARE MARKET
  • TABLE 3. GLOBAL CANCER REGISTRY SOFTWARE MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. GLOBAL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD MILLION)
  • TABLE 7. GLOBAL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY TYPE 2016-2026 (USD MILLION)
  • TABLE 8. GLOBAL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY DEPLOYMENT MODEL 2016-2026 (USD MILLION)
  • TABLE 9. GLOBAL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY DATABASE TYPE 2016-2026 (USD MILLION)
  • TABLE 10. GLOBAL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY FUNCTIONALITY 2016-2026 (USD MILLION)
  • TABLE 11. GLOBAL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD MILLION)
  • TABLE 12. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 13. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 14. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 15. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 16. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 17. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 18. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 19. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 20. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 21. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 22. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 23. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 24. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 25. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 26. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 27. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 28. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 29. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 30. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 31. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 32. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 33. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 34. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 35. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 36. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 37. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 38. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 39. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 40. U.S. CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 41. U.S. CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 42. U.S. CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 43. U.S. CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 44. U.S. CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 45. CANADA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 46. CANADA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 47. CANADA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 48. CANADA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 49. CANADA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 50. UK CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 51. UK CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 52. UK CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 53. UK CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 54. UK CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 55. GERMANY CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 56. GERMANY CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 57. GERMANY CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 58. GERMANY CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 59. GERMANY CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 60. ROE CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 61. ROE CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 62. ROE CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 63. ROE CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 64. ROE CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 65. CHINA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 66. CHINA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 67. CHINA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 68. CHINA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 69. CHINA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 70. INDIA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 71. INDIA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 72. INDIA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 73. INDIA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 74. INDIA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 75. JAPAN CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 76. JAPAN CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 77. JAPAN CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 78. JAPAN CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 79. JAPAN CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 80. ROAPAC CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 81. ROAPAC CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 82. ROAPAC CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 83. ROAPAC CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 84. ROAPAC CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 85. BRAZIL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 86. BRAZIL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 87. BRAZIL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 88. BRAZIL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 89. BRAZIL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 90. MEXICO CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 91. MEXICO CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 92. MEXICO CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 93. MEXICO CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 94. MEXICO CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 95. ROLA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 96. ROLA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 97. ROLA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 98. ROLA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 99. ROLA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 100. ROW CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 101. ROW CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 102. ROW CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 103. ROW CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 104. ROW CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

List of Figures

  • FIG 1. GLOBAL CANCER REGISTRY SOFTWARE MARKET, RESEARCH METHODOLOGY
  • FIG 2. GLOBAL CANCER REGISTRY SOFTWARE MARKET, MARKET ESTIMATION BUILDING TYPES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. GLOBAL CANCER REGISTRY SOFTWARE MARKET, KEY TRENDS 2018
  • FIG 5. GLOBAL CANCER REGISTRY SOFTWARE MARKET, GROWTH PROSPECTS 2019-2026
  • FIG 6. GLOBAL CANCER REGISTRY SOFTWARE MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. GLOBAL CANCER REGISTRY SOFTWARE MARKET, PEST ANALYSIS
  • FIG 8. GLOBAL CANCER REGISTRY SOFTWARE MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 10. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 11. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 12. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 13. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 14. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 15. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 16. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 17. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 18. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 19. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 20. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 21. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 22. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 23. GLOBAL CANCER REGISTRY SOFTWARE MARKET, REGIONAL SNAPSHOT 2016 & 2026
  • FIG 24. NORTH AMERICA CANCER REGISTRY SOFTWARE MARKET 2016 & 2026 (USD MILLION)
  • FIG 25. EUROPE CANCER REGISTRY SOFTWARE MARKET 2016 & 2026 (USD MILLION)
  • FIG 26. ASIA PACIFIC CANCER REGISTRY SOFTWARE MARKET 2016 & 2026 (USD MILLION)
  • FIG 27. LATIN AMERICA CANCER REGISTRY SOFTWARE MARKET 2016 & 2026 (USD MILLION)
  • FIG 28. GLOBAL CANCER REGISTRY SOFTWARE MARKET, COMPANY MARKET SHARE ANALYSIS (2018)